e8vk
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 9, 2007
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
(Exact name of Registrant as specified in its charter)
|
|
|
|
|
Delaware
(State or other jurisdiction of
incorporation or organization)
|
|
0-26224
(Commission File Number)
|
|
51-0317849
(I.R.S. Employer Identification No.) |
311 Enterprise Drive
Plainsboro, NJ 08536
(Address of principal executive offices) (Zip Code)
Registrants telephone number, including area code: (609) 275-0500
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On May 9, 2007, Integra LifeSciences Holdings Corporation issued a press release announcing
financial results for the quarter ended March 31, 2007. A copy of the press release is attached as
Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item.
The information contained in Item 2.02 of this Current Report on Form 8-K (including the press
release) is being furnished and shall not be deemed filed for the purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the
liabilities of that Section. The information contained in Item 2.02 of this Current Report on Form
8-K (including the press release) shall not be incorporated by reference into any registration
statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange
Act, except as shall be expressly set forth by specific reference in any such filing.
Discussion of Adjusted Financial Measures
In addition to our GAAP results, we provide adjusted net income and adjusted earnings per diluted
share. Adjusted net income consists of net income excluding acquisition-related charges,
facility consolidation, manufacturing transfer and system integration charges, certain
employee termination and related costs, charges associated with discontinued or withdrawn product
lines and income tax expense/benefit related to these adjustments. Adjusted earnings per diluted
share is calculated by dividing adjusted net income for diluted earnings per share by diluted
weighted average shares outstanding.
Integra believes that the presentation of adjusted net income and adjusted earnings per diluted
share provides important supplemental information to management and investors regarding financial
and business trends relating to the Companys financial condition and results of operations.
Management uses non-GAAP financial measures in the form of adjusted net income and adjusted
earnings per diluted share when evaluating operating performance because we believe that the
inclusion or exclusion of the items described below, for which the amounts and/or timing may vary
significantly depending upon the Companys acquisition and restructuring activities, provides a
supplemental measure of our operating results that facilitates comparability of our operating
performance from period to period, against our business model objectives, and against other
companies in our industry. We have chosen to provide this information to investors so they can
analyze our operating results in the same way that management does and use this information in
their assessment of our core business and the valuation of our Company.
Internally, adjusted net income and adjusted earnings per diluted share are significant measures
used by management for purposes of:
|
|
supplementing the financial results and forecasts reported to the Companys board of directors; |
|
|
evaluating, managing and benchmarking the operating performance of the Company; |
|
|
establishing internal operating budgets; |
|
|
determining compensation under bonus or other incentive programs; |
|
|
enhancing comparability from period to period; |
|
|
comparing performance with internal forecasts and targeted business models; and |
|
|
evaluating and valuing potential acquisition candidates. |
Adjusted net income reflects net income adjusted for the following items:
Acquisition-related charges. Acquisition-related charges include in-process research
and development charges, charges related to discontinued research and development projects for
product technologies that were made redundant by an acquisition and inventory fair value purchase
accounting adjustments. Inventory fair value purchase accounting adjustments consist of the
increase to cost of goods sold that occur as a result of expensing the step up in the fair value
of inventory that we purchased in connection with acquisitions as that inventory is sold during the
financial period. Although recurring given the ongoing character of our acquisition program, these
acquisition-related charges are not factored into the evaluation of our performance by management
after completion of acquisitions because they are of a temporary nature, they are not related to
our core operating performance and the frequency and amount of such charges vary significantly
based on the timing and magnitude of our acquisition transactions as well as the level of inventory
on hand at the time of acquisition.
Facility consolidation, manufacturing transfer and system integration charges. These
charges, which include employee termination and other costs associated with exit or disposal
activities and costs associated with the worldwide implementation of a single enterprise resource
planning system, result from rationalizing our existing manufacturing, distribution and
administrative infrastructure. Many of these cost-saving and efficiency-driven activities are
identified as opportunities in connection with acquisitions that provide the Company with
additional capacity or economies of scale. Although recurring in nature given managements ongoing
review of the efficiency of our manufacturing, distribution and administrative facilities and
operations, management excludes these items when evaluating the operating performance of the
Company because the frequency and amount of such charges vary significantly based on the timing and
magnitude of the Companys rationalization activities and are, in some cases, dependent upon
opportunities identified in acquisitions, which also vary in frequency and magnitude.
Employee termination and related costs. Employee termination and related costs consist
of charges related to significant reductions in force that are not initiated in connection with
facility consolidations or manufacturing transfers. Management excludes these items when
evaluating Integras operating performance because these amounts do not affect our core operations
and because of the infrequent and large-scale nature of these activities.
Charges associated with discontinued or withdrawn product lines. This represents a
charge taken in connection with a product line that the Company discontinued and reductions and
revenue and charges taken in connection with a product withdrawal. Management excludes this item
when evaluating Integras operating performance because of the infrequent nature of this activity.
Income tax expense (benefit). Income tax expense is adjusted by the amount of
additional tax expense or benefit that the Company estimates that it would record if it used
non-GAAP results instead of GAAP results in the calculation of its tax provision. Such additional
tax expense or benefit is calculated at the statutory rate applicable to jurisdictions in which
such non-GAAP adjustments relate.
Adjusted net income and adjusted earnings per diluted share are not calculated in accordance with
GAAP, and should be considered supplemental to, and not as a substitute for, or superior to,
financial measures calculated in accordance with GAAP. Non-GAAP financial measures have
limitations in that they do not reflect all of the costs or benefits associated with the operations
of the Companys business as determined in accordance with GAAP. As a result, you should not
consider these measures in isolation or as a substitute for analysis of Integras results as
reported under GAAP. Integra expects to continue to incur expenses of a nature similar to the
non-GAAP adjustments described above, and exclusion of these items from its adjusted net income
should not be construed as an inference that all of these costs are unusual, infrequent or
non-recurring. Some of the limitations in relying on adjusted net income and adjusted earnings per
diluted share are:
Integra periodically acquires other companies or businesses, and we expect to continue to incur
acquisition-related expenses and charges in the future. These costs can directly impact the amount
of the
Companys available funds or could include costs for aborted deals which may be significant and
reduce GAAP net income.
Although the charges related to the restructuring of our operations and changes to our
capital structure occur on a sporadic basis and the charges relating to the discontinued
and withdrawn product line did not previously occur, they may recur in the future and they are, in
many cases, cash charges that reduce our available cash. There is no assurance that we will not
incur other similar charges and expenditures in the future.
All of the adjustments have been tax effected at Integras actual tax rates. Depending on the
nature of the adjustments and the tax treatment of the underlying items, the effective tax rate
related to adjusted net income could differ significantly from the effective tax rate related to
GAAP income.
In the financial statements portion of its earnings press release for the first quarter of 2007,
which is attached hereto as Exhibit 99.1, the Company has included a reconciliation of GAAP net
income to adjusted net income and GAAP earnings per diluted share to adjusted earnings per diluted
share used by management for the quarters ended March 31, 2007 and 2006. Also included are
reconciliations for future periods.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits.
|
|
|
|
|
Exhibit Number |
|
Description of Exhibit |
|
99.1 |
|
|
Press release issued May 9, 2007 regarding earnings for the quarter ended March 31, 2007 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has
duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|
|
|
|
|
|
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
|
|
Date: May 9, 2007 |
By: |
/s/ Stuart M. Essig
|
|
|
|
Stuart M. Essig |
|
|
|
President and Chief Executive Officer |
|
|
Exhibit Index
|
|
|
|
|
Exhibit Number |
|
Description of Exhibit |
|
99.1 |
|
|
Press release issued May 9, 2007 regarding earnings for the quarter ended March 31, 2007 |